1. Home
  2. HLX vs TYRA Comparison

HLX vs TYRA Comparison

Compare HLX & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.73

Market Cap

1.2B

Sector

Energy

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$34.51

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
TYRA
Founded
1979
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
HLX
TYRA
Price
$8.73
$34.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$10.50
$44.63
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$876,561,000.00
N/A
Revenue This Year
$2.91
N/A
Revenue Next Year
$4.97
N/A
P/E Ratio
$41.62
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$6.42
52 Week High
$10.75
$38.00

Technical Indicators

Market Signals
Indicator
HLX
TYRA
Relative Strength Index (RSI) 48.30 56.05
Support Level $6.03 $30.10
Resistance Level $10.75 N/A
Average True Range (ATR) 0.42 2.35
MACD -0.12 0.06
Stochastic Oscillator 4.09 55.32

Price Performance

Historical Comparison
HLX
TYRA

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: